For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
The Europe market for osseointegration implants was valued at $XX million in 2018 and is projected to reach $XX million by 2027 at a CAGR of 6.60% from 2019 to 2027. The rise in demand for minimally invasive implants procedures and techniques has fuelled the growth of the market, which helps minimizes the associated number of complications in the procedure.
Europe is one of the major contributors toward the growth of the global osseointegration implants market due to the presence of a large number of the patient population base. The economies of the United Kingdom, Germany, France, Italy, Spain, Russia and the remaining European countries are forming the Rest of Europe regional segment are the major revenue contributors to the regional market.
Germany will show robust market progress throughout the forecast period, mainly because of the presence of established market players across the nation should favor industry growth in the upcoming years.
Henry Schein, Inc., Stryker Corporation, Zimmer Biomet Holdings Inc., Integrum AB, Institut Straumann, Danaher Corp., Smith and Nephew PLC, Dentsply Sirona Inc., Medtronic, Osstem Implant Co. Ltd., 3M Company, and Bicon LLC have been operating eminently in the osseointegration implants market.